Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-20-052335

10% owner bought 55,000 shares at $18.00 ($990,000)

  • 10% owner acquired 6,414,356 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
INTERWEST PARTNERS X LP 10% owner 2020-09-25 Purchase +55,000 $18.00 $990,000 55,000 D: show line 1 in the form
INTERWEST PARTNERS X LP 10% owner 2020-09-29 Conversion +1,620,101 1,675,101 D: show line 2 in the form
INTERWEST PARTNERS X LP 10% owner 2020-09-29 Conversion +3,488,398 5,163,499 D: show line 3 in the form
INTERWEST PARTNERS X LP 10% owner 2020-09-29 Conversion +1,040,654 6,204,153 D: show line 4 in the form
INTERWEST PARTNERS X LP 10% owner 2020-09-29 Conversion +265,203 6,469,356 D: show line 5 in the form
Open-market purchases · 55,000 sh · avg $18.00 · $990,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
INTERWEST PARTNERS X LP 10% owner 2020-09-29 Conversion · Series Seed Preferred Stock −1,620,101 0 D: show line 6 in the form
INTERWEST PARTNERS X LP 10% owner 2020-09-29 Conversion · Series A Preferred Stock −3,488,398 0 D: show line 7 in the form
INTERWEST PARTNERS X LP 10% owner 2020-09-29 Conversion · Series B Preferred Stock −1,040,654 0 D: show line 8 in the form
INTERWEST PARTNERS X LP 10% owner 2020-09-29 Conversion · Series C Preferred Stock −265,203 0 D: show line 9 in the form
Loading xslF345X03/doc4.xml…